DARWIN EU® - Sex-specific incidence of selected adverse events for major cardio-metabolic drug classes

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000001081
• Study ID:
  1000001081
• Official title and acronym:
  DARWIN EU® - Sex-specific incidence of selected adverse events for major cardio-metabolic drug classes
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  Finland

  Germany

  Netherlands

  Spain

  United Kingdom
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Department of Medical Informatics - Health Data Science, Erasmus Medical Center (ErasmusMC)

Netherlands

Networks

Data Analysis and Real World Interrogation Network (DARWIN EU®)

Belgium

Croatia

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Italy

Netherlands

Norway

Portugal

Spain

Sweden

United Kingdom

Study timelines

Date when funding contract was signed

Planned:12/06/2026

Actual:12/06/2026

Study start date

Planned:05/08/2026

Actual:05/08/2026

Date of final study report

Planned:31/10/2026

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable